Quick Takeaways
- CELU - Celularity Inc financial facts are built from SEC company filings data.
- Latest metrics period on this page: Q3 2025.
- Headline metric: Return On Invested Capital -248%.
Professional SEC-based dashboard for profitability, financial health, and growth with transparent scoring logic. Latest period: Q3 2025.
Facts and ratios are grounded in SEC company facts linked to the latest 10-Q/10-K cycle.
See Original FilingLatest SEC snapshot (2025-09-30) highlights Return On Invested Capital -248.0%, Return On Equity 5731.8%, and Return On Assets -66.4%.
Transparent 0-100 scoring model based on profitability, financial health, and growth factors.
18.2/100
Weak Confidence high
-248%
Metric score 0.0/100
5732%
Metric score 100.0/100
-66%
Metric score 0.0/100
Return On Equity
Return On Invested Capital, Return On Assets, and Operating Margin
Return On Invested Capital
-248%
YoY:
Return On Equity
5732%
YoY: -3986%
Industry median: -43% (n=675)
Return On Assets
-66%
YoY: +171%
Industry median: -47% (n=673)
Operating Margin
-120%
YoY: +266%
Industry median: -121% (n=298)
Current Ratio
0.16x
YoY: -15%
Industry median: 3.39x (n=667)
Quick Ratio
0.12x
YoY: -11%
Industry median: 1.51x (n=289)
Debt-to-equity
-1.78x
YoY: -148%
Industry median: 0.26x (n=530)
Revenues YoY
-16%
YoY:
Industry median: 7.3% (n=302)
NetIncomeLoss YoY
-130%
YoY:
Industry median: -0.93% (n=641)
| Metric | Latest value | YoY change |
|---|---|---|
| Return On Invested Capital | -248% | |
| Return On Equity | 5732% | -3986% |
| Return On Assets | -66% | +171% |
| Operating Margin | -120% | +266% |
| Metric | Latest value | YoY change |
|---|---|---|
| Current Ratio | 0.16x | -15% |
| Quick Ratio | 0.12x | -11% |
| Debt-to-equity | -1.78x | -148% |
| Metric | Latest value | YoY change |
|---|---|---|
| Revenues YoY | -16% | |
| NetIncomeLoss YoY | -130% |
| Metric | Latest value | YoY change |
|---|---|---|
| Entity Common Stock, Shares Outstanding | 26,691,477 | +21% |
| Common Stock, Shares, Outstanding | 28,216,485 | +28% |
| Common Stock, Value, Issued | $3,000 | +50% |
| Weighted Average Number of Shares Outstanding, Basic | 26,347,818 | +20% |
| Weighted Average Number of Shares Outstanding, Diluted | 26,347,818 | +20% |
This score is transparent and deterministic. We weight profitability, financial health, and growth metrics, then renormalize weights when SEC data is missing.
| Metric | Weight | V1 threshold |
|---|---|---|
| ROIC | 20 | 5% to 20% |
| ROE | 15 | 8% to 25% |
| ROA | 10 | 2% to 10% |
| Operating Margin | 5 | 5% to 25% |
| Current Ratio | 12 | 1.0x to 2.0x |
| Quick Ratio | 8 | 0.8x to 1.5x |
| Debt to Equity | 10 | 0.3x to 2.0x (lower is better) |
| Revenue YoY | 10 | -10% to +20% |
| Net Income YoY | 10 | -10% to +20% |
Metrics are computed with a market-consensus convention designed for cross-portal comparability.